Clinical and Translational Oncology

, Volume 13, Issue 1, pp 50–56 | Cite as

The EORTC quality of life questionnaire for patients with colorectal cancer: EORTC QLQ-CR29 validation study for Spanish patients

  • Juan Ignacio Arraras
  • Javier Suárez
  • Fernando Arias de la Vega
  • Ruth Vera
  • Gemma Asín
  • Virginia Arrazubi
  • Mikel Rico
  • Lucía Teijeira
  • Jaione Azparren
Research Articles



The EORTC Quality of Life (QL) Group has developed a questionnaire -the EORTC QLQ-CR29- for evaluating QL in colorectal cancer. The aim of this study is to assess the psychometric properties of the EORTC QLQ-CR29 when applied to a sample of Spanish patients.

Materials and methods

Eighty-four locally advanced rectal cancer patients in the treatment follow-up period after receiving surgery and neoadjuvant chemoradiotherapy were included in the study. Seventy subjects also had adjuvant chemotherapy. Patients completed both the EORTC QLQ-C30 and the QLQ-CR29 once. The psychometric evaluation of the questionnaire’s structure, reliability, and convergent, divergent and known-groups validity was performed.


Multitrait scaling analysis showed that three of the multi-item scales met the standards of convergent and discriminant validity. These same scales reached the 0.7 Cronbach’s coefficient criterion or were close to it. In both analyses exceptions were observed in the blood and mucus in stool scale. Correlations between the scales of the QLQ-C30 and the module were low (r<0.02) in most cases. A few areas with more related content had higher correlations (r<0.05). Group comparison analyses showed differences in QL between groups of patients based on age, comorbidity, performance status, receipt of adjuvant chemotherapy and surgery modality.


The EORTC QLQ-CR29 is a reliable and valid instrument when applied to a sample of Spanish rectal cancer patients. These results are in line with those of the EORTC validation study.


Cancer Colorectal Quality of life Validation Spanish Questionnaire 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase N°5, version 2.0. IARC Press, LyonGoogle Scholar
  2. 2.
    Libutti S, Saltz L, Tepper J (2008) Colon cancer. In: De Vita V, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 8th edn. Lippincott, Williams and Wilkins, Philadelphia, pp 1232–1277Google Scholar
  3. 3.
    Libutti S, Tepper J, Saltz L (2008) Rectal cancer. In: De Vita V, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 8th edn. Lippincott, Williams and Wilkins, Philadelphia, pp 1285–1298Google Scholar
  4. 4.
    American Society of Clinical Oncology (1996) Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 14:671–679Google Scholar
  5. 5.
    Aaronson NK, Ahmezdai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a Quality of Life instrument for use in intentional clinical trials. J Natl Cancer Inst 85:365–376CrossRefPubMedGoogle Scholar
  6. 6.
    Aaronson NK, Cull A, Kaasa S et al (1994) The EORTC modular approach to Quality of Life assessment in oncology. Int J Ment Health 23:75–96Google Scholar
  7. 7.
    Sprangers MAG, te Velde A, Aaronson NK (1999) The construction and testing of the EORTC Colorectal Cancer-specific Quality of Life Questionnaire Module (QLQ-CR38). Eur J Cancer 35:238–247CrossRefPubMedGoogle Scholar
  8. 8.
    Arraras JI, Vera R, Manterota A et al (2003) El cuestionario de Calidad de Vida para cáncer colorectal EORTC QLQ-CR38. Estudio de validación para nuestro país. Oncología 26:285–292Google Scholar
  9. 9.
    Korolija D, Sauerland S, Wood-Dauphinee S et al (2004) Evaluation of quality of life after laparoscopic surgery: evidence-based guidelines of the European Association for Endoscopic Surgery. Surg Endosc 18:879–897CrossRefPubMedGoogle Scholar
  10. 10.
    Efficace F, Bottomley A, Vanvoorden V, Blazeby JM (2004) Methodological issues in assessing health-related quality of life of colorectal cancer patients in randomised controlled trials. Eur J Cancer 40:187–197CrossRefPubMedGoogle Scholar
  11. 11.
    Ward WL, Hahn EA, Mo F et al (1999) Reliability and validity of the functional assessment of cancer therapy colorectal (FACT-C) quality of life instrument. Qual Life Res 8:181–195CrossRefPubMedGoogle Scholar
  12. 12.
    Whistance RN, Conroy T, Chie W et al (2009) Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer. Eur J Cancer 45:3017–3026CrossRefPubMedGoogle Scholar
  13. 13.
    Bjordal K, de Graeff A, Fayers PM et al (2000) A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. Eur J Cancer 36:1796–1807CrossRefPubMedGoogle Scholar
  14. 14.
    Arraras JI, Arias F, Tejedor M et al (2002) The EORTC QLQ-C30 (version 3.0) quality of life questionnaire. Validation study for Spain with head and neck cancer patients. Psychooncology 11:249–256CrossRefPubMedGoogle Scholar
  15. 15.
    Arraras JI, Villafranca E, Arias F et al (2008) The EORTC Quality of life questionnaire QLQ-C30 (version 3.0). Validation study for Spanish prostate cancer patients. Arch Esp Urol 61:949–954Google Scholar
  16. 16.
    Cull A, Sprangers M, Bjordal K et al (2002) EORTC Quality of Life Group translation procedure, 2nd edn. EORTC, BrusselsGoogle Scholar
  17. 17.
    Karnofsky DA, Burchenal JH (1948) The clinical evaluation of chemotherapeutic agents in cancer. In: McLeod CM (ed.) Evaluation of chemotherapeutic agents. Colombia University, New York, pp 199–205Google Scholar
  18. 18.
    Ware JE, Harris WJ, Gandek B et al (1997) MAP-R for Windows: Multitrait Multi-Item Analysis Program-revised user’s guide. Health Assessment Lab, BostonGoogle Scholar
  19. 19.
    Cronbach LJ (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16:297CrossRefGoogle Scholar
  20. 20.
    Arraras JI, Vera R, Martínez M et al (2006) Quality of Life assessment through the EORTC questionnaires of colorectal cancer patients in advanced disease stages. Clin Transl Oncol 8:664–671CrossRefGoogle Scholar
  21. 21.
    Arraras JI, Arias F, Vera R et al (2006) Quality of Life assessment through the EORTC questionnaires of locally advanced rectal cancer patients treated with preoperative chemo-radiotherapy. Clin Transl Oncol 8:423–429CrossRefGoogle Scholar
  22. 22.
    Song PH, Yun SM, Kim JH, Moon KH (2010) Comparison of the erectile function in male patients with rectal cancer treated by preoperative radiotherapy followed by surgery and surgery alone. Int J Colorectal Dis 25:619–624CrossRefPubMedGoogle Scholar

Copyright information

© Feseo 2011

Authors and Affiliations

  • Juan Ignacio Arraras
    • 1
    • 2
    • 4
  • Javier Suárez
    • 3
  • Fernando Arias de la Vega
    • 1
  • Ruth Vera
    • 2
  • Gemma Asín
    • 1
  • Virginia Arrazubi
    • 2
  • Mikel Rico
    • 1
  • Lucía Teijeira
    • 2
  • Jaione Azparren
    • 2
  1. 1.Radiotherapeutic Oncology DepartmentHospital de NavarraPamplona, NavarraSpain
  2. 2.Medical Oncology DepartmentHospital de NavarraPamplona, NavarraSpain
  3. 3.Surgery DepartmentHospital de NavarraPamplona, NavarraSpain
  4. 4.Pamplona, NavarraSpain

Personalised recommendations